AB Science announces that two financial analysis firms, DNA Finance and In Extenso Finance, have initiated coverage of the Company
AB Science SA (Euronext - FR0010557264 - AB) announces that two financial analysis firms, DNA Finance and In Extenso Finance, have initiated the coverage of the Company.
- AB Science SA (Euronext - FR0010557264 - AB) announces that two financial analysis firms, DNA Finance and In Extenso Finance, have initiated the coverage of the Company.
- DNA Finance estimates that AB Science stands out as a compelling investment opportunity in the biotech sector.
- These new coverages aim to strengthen the AB Science visibility among French and international institutional investors and to broaden its investor base.
- Both DNA Finance and In Extenso reports are available on the AB Science’s website in the "Analysts coverage" section: https://www.ab-science.com/investors/analyst-coverage/
DNA Finance specialises in equity research for listed companies in the healthcare sector.